Search - tctmd.com

Displaying 681 - 700 of 1127

Sort: Relevancy | Date

News Conference News AHA 2017

‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18

Michael O'Riordan

November 15, 2017

News Conference News AHA 2017

GEMINI-ACS-1 Substudy: P2Y12 Inhibitor Switching Is Uncommon After ACS

Yael L. Maxwell

November 14, 2017

News Conference News AHA 2017

DACAB: Ticagrelor and Aspirin Improve SVG Patency at 1 Year Post-CABG vs Monotherapy

Yael L. Maxwell

November 12, 2017

News Conference News AHA 2017

Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List

Michael O'Riordan

November 12, 2017

News Conference News AHA 2017

Low High-Sensitivity Troponin I Cutoff May Allow Discharge From ED for Many

Todd Neale

November 11, 2017

News Conference News TCT 2017

DES With Bioresorbable Polymer Outperforms BMS in SENIOR Patients

Michael O'Riordan

November 01, 2017

News Conference News TCT 2017

Long-term Absorb BVS Data Continue to Disappoint

Michael O'Riordan

October 31, 2017

Presentation TCT 2017

Case Resolution: A Patient With Stable Angina Our Approach and Outcome

Presenter: Sripal Bangalore, Manesh R. Patel, Adhir Shroff

October 30, 2017

Presentation TCT 2017

Revascularization in Stable Ischemic Heart Disease: What Do the US Guidelines and AUC Say?

Presenter: Sripal Bangalore, Manesh R. Patel, David J. Maron

October 30, 2017

Presentation TCT 2017

Revascularization in Stable Ischemic Heart Disease: What Do the Data and EU Guidelines Say?

Presenter: Sripal Bangalore, Manesh R. Patel, Carlo Di Mario

October 30, 2017

Presentation TCT 2017

Case Introduction: A Patient With Stable Angina How Should We Evaluate and Treat?

Presenter: Sripal Bangalore, Manesh R. Patel, Adhir Shroff

October 30, 2017

News Conference News TCT 2017

Help for Clinicians Whose Patients Need to Switch P2Y12 Inhibitors

Todd Neale

October 30, 2017

News Daily News

Applying the AUC: Teaching, Screening Make a Difference in Unneeded Invasive Tests

Caitlin E. Cox

October 24, 2017

News Daily News

Lesion Complexity and Patient Risk: A Balancing Act for DAPT Duration

Yael L. Maxwell

October 23, 2017

News Daily News

Women, Minorities at Greater Risk for Non-Stent-Related Events After PCI

Yael L. Maxwell

October 20, 2017

Manuscript

Ischemic Cardiomyopathy: An Oxymoron?

October 16, 2017

News Daily News

Bleeding and Ischemic Events Fluctuate Out to 1 Year Post-STEMI: HORIZONS-AMI

Yael L. Maxwell

October 03, 2017

Presentation

Characterization of the Average Daily Ischemic and Bleeding Risk After Primary PCI for STEMI

October 03, 2017

News Daily News

No Anticoagulation Benefit, High Bleeding Risk Seen in Patients With Secondary A-fib

Michael O'Riordan

September 29, 2017

News Daily News

Ischemic Heart Disease the Leading Cause of Death Globally

Michael O'Riordan

September 19, 2017

Advertisement

‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18

GEMINI-ACS-1 Substudy: P2Y12 Inhibitor Switching Is Uncommon After ACS

DACAB: Ticagrelor and Aspirin Improve SVG Patency at 1 Year Post-CABG vs Monotherapy

Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List

Low High-Sensitivity Troponin I Cutoff May Allow Discharge From ED for Many

DES With Bioresorbable Polymer Outperforms BMS in SENIOR Patients

Long-term Absorb BVS Data Continue to Disappoint

Case Resolution: A Patient With Stable Angina Our Approach and Outcome

Revascularization in Stable Ischemic Heart Disease: What Do the US Guidelines and AUC Say?

Revascularization in Stable Ischemic Heart Disease: What Do the Data and EU Guidelines Say?

Case Introduction: A Patient With Stable Angina How Should We Evaluate and Treat?

Help for Clinicians Whose Patients Need to Switch P2Y12 Inhibitors

Applying the AUC: Teaching, Screening Make a Difference in Unneeded Invasive Tests

Lesion Complexity and Patient Risk: A Balancing Act for DAPT Duration

Women, Minorities at Greater Risk for Non-Stent-Related Events After PCI

Ischemic Cardiomyopathy: An Oxymoron?

Bleeding and Ischemic Events Fluctuate Out to 1 Year Post-STEMI: HORIZONS-AMI

Characterization of the Average Daily Ischemic and Bleeding Risk After Primary PCI for STEMI

No Anticoagulation Benefit, High Bleeding Risk Seen in Patients With Secondary A-fib

Ischemic Heart Disease the Leading Cause of Death Globally

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content